@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix go: . @prefix species: . @prefix occursIn: . @prefix mesh: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: hgnc:6596; a Protein: . sub:_2 occursIn: mesh:D018482, mesh:D032496, species:9606; rdf:object go:0030239; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(HGNC:LIF) -> bp(GO:\"myofibril assembly\")" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "1.4" . sub:_3 prov:value "in vitro, LIF stimulates myoblast growth via direct receptor-mediated mechanisms without affecting myoblast differentiation and fusion in vivo, administration of LIF to the site of muscle injury results in increased rate of muscle regeneration, characterized by increased myoblast proliferation and increased regenerated myofiber number and size"; prov:wasQuotedFrom pubmed:14715915 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:14715915; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:19.730+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }